It is proposed to develop an approach for constructing enzyme-based sensors for detecting biomolecules. The sensor is an enzyme modified by site-directed mutagenesis to create a binding site specific for a target biomolecule. A library of engineered enzyme sensors is constructed to serve as a repository of potential binders. The binding site is positioned in the immediate vicinity of the enzyme's active site such that the active site is allosterically affected by the binding of the biomolecule to the binding site. Binding is detected in a chemical reaction catalyzed by the enzyme using a chromogenic or fluorogenic substrate. Implementation will be straightforward and as simple as adding the biomolecule of interest, or a sample that contains it, to the enzyme sensor and observing the outcome of the reaction (i.e., color or fluorescence).

Public Health Relevance

The project will result in creation of a general approach to obtain enzyme-based sensors capable of detecting the presence of biomolecules and automatically signaling their presence. The approach can be used in research and development, molecular diagnostic testing and drug discovery. The ease of testing allows the method to be applied broadly.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43GM133228-01
Application #
9776983
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Krepkiy, Dmitriy
Project Start
2019-05-01
Project End
2021-04-30
Budget Start
2019-05-01
Budget End
2021-04-30
Support Year
1
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Pharmaseq, Inc.
Department
Type
DUNS #
027661870
City
Monmouth Junction
State
NJ
Country
United States
Zip Code
08852